SCHEMBL7535294

SCHEMBL7535294

Cc1nc(Cl)sc1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5154036 0.72
SCHEMBL3375995 0.72
SCHEMBL13700990 0.72
SCHEMBL15751859 0.72
Hydrochloric Acid SCHEMBL28926886 0.70
SCHEMBL4104913 0.68
SCHEMBL7724511 0.68
SCHEMBL25916784 0.68
SCHEMBL2514326 0.67 ALDH1A1 (1.00)
Hydrochloric Acid SCHEMBL8761196 0.66 ALDH1A1 (0.96)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1202979-A1 PROCESS FOR THE PREPARATION OF THIAZOLE DERIVATIVES Syngenta Participations AG (CH) 2002-05-08 EP claimed
WO-2001010852-A1 PROCESS FOR THE PREPARATION OF THIAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2001-02-15 WO claimed
US-11760762-B2 Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors SIGNALRX PHARMACEUTICALS, INC. (US) 2023-09-19 US disclosed
US-11760762-B2 Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors SIGNALRX PHARMACEUTICALS, INC. (US) 2023-09-19 US disclosed